GlassScriptPhysician profile
Arthur E Desrosiers
NPI 1770700429
$155,725.53
in general payments reported to CMS, 2019-2025
30 companies · $18K in 2025
The $18K reported for 2025 was more than what 97% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36K · 2020: $15K · 2021: $22K · 2022: $25K · 2023: $29K · 2024: $11K · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $41K · Food and Beverage: $9,004 · Travel and Lodging: $5,425 · Consulting Fee: $3,364.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $40,840.50 |
| Food and Beverage | $9,004.37 |
| Travel and Lodging | $5,424.79 |
| Consulting Fee | $3,363.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $122,721.53 | 2019-2025 | Puraply Wound Matrix, Puraply Antimicrobial, Puraply |
| Sanara Medtech INC. | $12,433.43 | 2020-2024 | Celleraterx |
| Aroa Biosurgery Incorporated | $6,676.77 | 2022-2024 | |
| Stryker Corporation | $2,271.56 | 2020-2024 | Salvation, Prophecy |
| Integra Lifesciences Corporation | $2,040.06 | 2019-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Kci USA, INC. | $1,651.12 | 2019-2022 | |
| Polynovo North America LLC | $1,466.41 | 2021-2025 | Novosorb Btm |
| Tela Bio, INC. | $1,449.25 | 2019-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Smith+Nephew, INC. | $937.50 | 2019-2025 | Renasys Touch, Pico, Pico 14 |
| Musculoskeletal Transplant Foundation INC. | $591.50 | 2022-2024 | |
| Abbvie INC. | $578.56 | 2023-2024 | Natrelle Saline-Filled Breast Implants |
| Sientra, INC. | $364.74 | 2021-2022 | |
| Kerecis Limited | $356.53 | 2021-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Polymedics Innovations INC. | $255.69 | 2022 | |
| Next Science LLC | $244.96 | 2023 | Xperience, Blastx, Surgx |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $212.66 | 2022-2023 | |
| Triad Life Sciences INC. | $197.25 | 2022 | |
| Zimmer Biomet Holdings, INC. | $175.44 | 2019 | |
| Galderma Laboratories, L.P. | $150.00 | 2020 | |
| Wright Medical Technology, INC. | $147.84 | 2020 | |
| Osteomed LLC | $147.19 | 2021 | |
| Bone Support INC. | $137.90 | 2025 | Cerament G, Ceramentbone Void Filler |
| Wound Management Technologies, INC | $120.47 | 2019 | |
| Innocoll Pharmaceuticals Limited | $112.87 | 2022 | |
| Medline Industries LP | $86.79 | 2019 | |
| Axogen | $75.32 | 2019 | |
| Biocomposites INC | $46.33 | 2019 | |
| Allergan, INC. | $31.23 | 2022 | |
| Innovation Technologies INC | $29.25 | 2023 | Irrisept |
| Acera Surgical, INC. | $15.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arthur Desrosiers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.